Please check your internet connection and try again.
# Mega%20cv
**Uncertainty:** The name "Mega cv" is not a standard pharmaceutical name. It most likely refers to **amoxicillin/clavulanate** (co-amoxiclav, e.g., Augmentin). The following information is based on that assumption. Verify product and local formulation before use.
## Overview
- Combination antibiotic: amoxicillin (aminopenicillin) + clavulanate (beta-lactamase inhibitor).
- Activity against many gram-positive, gram-negative, and anaerobic bacteria, including beta-lactamase producers.
## Primary Indications
- Respiratory tract infections (including acute otitis media, sinusitis, community-acquired pneumonia)
- Urinary tract infections
- Skin and soft tissue infections
- Bone and joint infections
- Mixed aerobic-anaerobic infections (e.g., diabetic foot, intra-abdominal)
## Adult Dosing
Dose expressed as amoxicillin/clavulanate. Ratio varies (e.g., 4:1, 7:1, 14:1). Use local guidelines.
- **Mild-moderate infection (e.g., sinusitis, UTI):** 500/125 mg orally every 8 hours **or** 875/125 mg orally every 12 hours.
- **Severe infection (e.g., pneumonia, complicated skin):** 875/125 mg orally every 12 hours or 1 g (amoxicillin)/125 mg IV every 8 hours (or 1 g/200 mg every 8 hours, depending on formulation).
- **Maximum:** 3 g amoxicillin/day (oral); IV doses may go higher (e.g., 1.2 g every 6-8 hours, up to 3.6 g amoxicillin/day). Follow local protocol.
## Pediatric Dosing
Dose based on amoxicillin component. Use weight-based dosing. Follow local guidelines for specific infections.
- Oral suspension: **45 mg/kg/day amoxicillin divided every 12 hours** (using 7:1 ratio) **or** **40-45 mg/kg/day divided every 8 hours** (using 4:1 ratio).
- For severe infections (e.g., otitis media): **80-90 mg/kg/day amoxicillin divided every 12 hours** (using 14:1 ratio, available in some countries).
- IV: Usually **30 mg/kg every 8 hours** (amoxicillin component) for moderate infections; up to **50 mg/kg every 6-8 hours** for severe. Max amoxicillin dose often **3 g/day** in children >40 kg.
## Dose Adjustments
- **Renal impairment:**
- CrCl 10-30 mL/min: Extend dosing interval (e.g., every 12-18 hours for standard oral doses).
- CrCl <10 mL/min: Every 24 hours (or avoid).
- Hemodialysis: Administer after dialysis.
- **Hepatic impairment:** Caution; monitor liver function. Contraindicated in severe liver disease with history of cholestatic jaundice related to amoxicillin/clavulanate.
## Contraindications
- History of allergic reaction to penicillins or beta-lactams.
- Previous amoxicillin/clavulanate-associated jaundice or hepatic dysfunction.
- Severe renal impairment with CrCl <10 mL/min (unless alternative available).
## Adverse Effects
- **Common:** Diarrhea (more frequent with clavulanate), nausea, vomiting, rash.
- **Serious:** Anaphylaxis, Stevens-Johnson syndrome, cholestatic hepatitis (especially in elderly, prolonged therapy), Clostridioides difficile colitis.
## Key Drug Interactions
- **Methotrexate:** Increased risk of methotrexate toxicity.
- **Warfarin:** Enhanced anticoagulant effect (monitor INR).
- **Allopurinol:** Increased risk of rash.
- **Oral contraceptives:** May reduce efficacy (use additional contraception).
## Monitoring
- Baseline renal and hepatic function (especially in elderly, prolonged therapy).
- Signs of hypersensitivity (rash, urticaria, anaphylaxis).
- Diarrhea (assess for C. difficile in persistent cases).
- Periodic CBC and LFTs if therapy >7 days.
## Clinical Pearls
- Take with food to reduce GI upset.
- Diarrhea from clavulanate is dose-related; consider lower dose (e.g., 8-hour regimen uses less clavulanate per dose).
- Not effective against MRSA, Pseudomonas (unless high-dose amoxicillin for sensitive strains).
- For suspected aspiration pneumonia (oral anaerobes) – good coverage.
- Augmentin ES (600 mg per 5 mL) is specifically for pediatric otitis media (14:1 ratio). Verify product.
---
*This information is an educational summary. Always verify current prescribing information, local formulary, and susceptibility patterns. Dosing may vary by indication and local protocol.*